Landos Biopharma, Inc.

NASDAQ:LABP

22.93 (USD) • At close May 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -21.935-39.276-38.422-30.144-13.467-6.044
Depreciation & Amortization 0.0440.5770.1960.1370.1030.08
Deferred Income Tax 2.129000.29300
Stock Based Compensation 0.9711.9714.1180.83300
Change In Working Capital 0.443-10.0745.8915.8713.277-1.301
Accounts Receivables 000-0.1532.0910
Inventory 0000.153-2.0910
Accounts Payables -2.129-9.4734.2636.5060.4151.002
Other Working Capital 2.572-0.6011.628-0.6352.862-2.303
Other Non Cash Items -2.1291.0311.1560.0480.2130.369
Operating Cash Flow -20.477-45.771-27.061-22.962-9.874-6.896
Investing Activities:
Investments In Property Plant And Equipment 0-0.007-0.44-0.181-0.158-0.043
Acquisitions Net 00.236-0.2350.08800
Purchases Of Investments 0-3.671-174.853-21.718-40.3190
Sales Maturities Of Investments 7.77577.502116.58736.030.1520
Other Investing Activites -0.05700.235-0.08800
Investing Cash Flow 7.77574.06-58.70614.131-40.325-0.043
Financing Activities:
Debt Repayment 000000
Common Stock Issued 16.5670931.51851.6680
Common Stock Repurchased -300000
Dividends Paid 000000
Other Financing Activities -30-1.39307.985
Financing Cash Flow 13.567091.6071.51859.6485
Other Information:
Effect Of Forex Changes On Cash 0.0440.0460.049-0.07900
Net Change In Cash 0.90928.3355.889-7.3929.449-1.939
Cash At End Of Period 37.54936.648.3052.4169.8080.359